Steeve Néron
Corporate Officer/Principal bei TETRA BIO-PHARMA INC.
Aktive Positionen von Steeve Néron
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TETRA BIO-PHARMA INC. | Corporate Officer/Principal | 17.09.2020 | - |
| Geschäftsführer | 01.11.2019 | - | |
| Vertrieb & Marketing | 13.11.2018 | 01.11.2019 | |
TALLC Corp., Inc.
 TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Steeve Néron
Ehemalige bekannte Positionen von Steeve Néron
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Valeant Canada Ltd.
 Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Corporate Officer/Principal | 01.05.2013 | 01.02.2018 |
Ausbildung von Steeve Néron
| Université du Québec à Chicoutimi | Undergraduate Degree |
Statistik
International
| Kanada | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Sales & Marketing | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| TETRA BIO-PHARMA INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Health Technology |
TALLC Corp., Inc.
TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada. | Health Technology |
- Börse
- Insiders
- Steeve Néron
- Erfahrung